Total investments received (USD): 193.02m
Round value (USD): 80m
Company: Oculis Pharma
Industry:
Pharma



Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom